EP2872914B1 - Prediction, scoring, and classification of magnetic resonance contrast using a contrast signal scoring equation - Google Patents

Prediction, scoring, and classification of magnetic resonance contrast using a contrast signal scoring equation Download PDF

Info

Publication number
EP2872914B1
EP2872914B1 EP13766693.9A EP13766693A EP2872914B1 EP 2872914 B1 EP2872914 B1 EP 2872914B1 EP 13766693 A EP13766693 A EP 13766693A EP 2872914 B1 EP2872914 B1 EP 2872914B1
Authority
EP
European Patent Office
Prior art keywords
contrast
magnetic resonance
type
score
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP13766693.9A
Other languages
German (de)
French (fr)
Other versions
EP2872914A2 (en
Inventor
Julien Senegas
Peter Koken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips GmbH
Koninklijke Philips NV
Original Assignee
Philips GmbH
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips GmbH, Koninklijke Philips NV filed Critical Philips GmbH
Publication of EP2872914A2 publication Critical patent/EP2872914A2/en
Application granted granted Critical
Publication of EP2872914B1 publication Critical patent/EP2872914B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/543Control of the operation of the MR system, e.g. setting of acquisition parameters prior to or during MR data acquisition, dynamic shimming, use of one or more scout images for scan plane prescription
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/746Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475User input or interface means, e.g. keyboard, pointing device, joystick
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0475Special features of memory means, e.g. removable memory cards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2576/00Medical imaging apparatus involving image processing or analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5602Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution by filtering or weighting based on different relaxation times within the sample, e.g. T1 weighting using an inversion pulse

Definitions

  • the following relates to the magnetic resonance arts, magnetic resonance imaging arts, medical imaging arts, imaging session planning arts, image archiving arts, imaging protocol design arts, and so forth.
  • MR magnetic resonance
  • a radiologist or other operator selects an imaging protocol which defines the structure of the sequence, e.g. the number and arrangement of radio frequency (RF) and magnetic field gradient pulses, readout operations, and so forth.
  • the imaging protocol is usually designed to provide a particular type of contrast, e.g. T1 contrast, T2 contrast, T2* contrast, diffusion weighted contrast, or so forth.
  • T1, T2, or T2* contrast the imaging provides contrast for differences in the T1, T2, or T2* (resp.) relaxation time of the tissue or other substance being imaged.
  • Protocol parameters such as the time-to-echo (TE), sequence repetition time (TR), excitation flip angle (FA), and so forth affect the strength of T1, T2, or T2* contrast.
  • the protocol includes preparatory or magnetic resonance-manipulative RF pulses and/or magnetic field gradients that are applied to generate the desired contrast.
  • the protocol is designed to provide contrast based on local molecular diffusion characteristics.
  • a given protocol has a set of parameters (e.g., TE, TR, FA, parameters defining a preparatory pulse, or so forth).
  • the parameters may have different representations in different protocols.
  • the number of slices may be specified, and the TR value then calculated to be as small as possible (e.g., to facilitate rapid imaging).
  • adjusting the number of slices impacts the TR value.
  • the radiologist may increase or decrease the number of slices in order to adjust image resolution transverse to the slices, or to increase the total imaging volume. In doing so, the radiologist may fail to appreciate that the value of the TR parameter is simultaneously being adjusted.
  • the radiologist typically has available a library of protocols tailored for various contrast types and for various tissue types.
  • Each protocol usually includes a set of default parameter values, e.g. a default TE, TR, FA, et cetera.
  • the radiologist is not limited to these default parameter values, however, but instead has the option to adjust some or all of the parameter values to optimize the protocol for a particular patient, for a particular imaging situation, or to accommodate personal preferences of the radiologist or of the physician ordering the MR study.
  • Adjusting the protocol parameters requires expert training, and the MR operator is typically a trained radiologist or otherwise qualified person.
  • the radiologist may reference recommendations from MR literature, a published user guide for the MR scanner, Internet-based radiology user forums, or so forth.
  • the radiologist has a scheduled time window in which to perform an imaging session, and usually relies upon personal expertise in making protocol parameter adjustments. It can happen that subtle changes in the parameters have an undesired influence on the resulting image contrast. For example, as already noted, adjusting the slice number in a multi-slice imaging protocol can have a latent impact on the TR value, which in turn can impact contrast.
  • a given MR image may exhibit a blend of different contrast types, e.g. predominantly T2 contrast but with some T1 contrast as well, and different persons may have different views as to whether a given image exhibits "adequate" T2 contrast.
  • the MR images may be misinterpreted, or the entire MR study may need to be redone, which is inconvenient for the patient, costly, and can lead to delay in medical treatment.
  • a Picture Archiving and Communications Service is typically employed to archive medical images, for example stored in accord with the Digital Imaging and COmmunication in Medicine (DICOM) standard.
  • a patient's MR images may be compared with images stored in a PACS in order to identify similar cases. While such comparisons can be medically useful, the validity of the comparison can be compromised if the image contrast is different in the patient and archive images. The likelihood of such a difference is increased if the PACS archives images from multiple medical facilities or different imaging laboratories that use different contrast standards. Haacke et al., Magnetic Resonance Imaging.
  • U.S. Patent 6, 687,527 B1 discloses a system, wherein an image contrast weighting, especially a T1, a T2 and a proton density weighting are determined and displayed, once the user has selected imaging parameters.
  • the invention concerns a non-transitory storage medium storing instructions executable by an electronic data processing device to perform a method including:
  • One advantage resides in providing real-time feedback on the impact of protocol parameter adjustments on the expected image contrast.
  • Another advantage resides in providing a principled approach for labeling MR imaging protocols and archived MR images as pertaining to image contrast type.
  • the invention may take form in various components and arrangements of components, and in various process operations and arrangements of process operations.
  • the drawings are only for the purpose of illustrating preferred embodiments and are not to be construed as limiting the invention.
  • amagnetic resonance (MR) scanner 10 is operated by a radiologist or other user via an MR scanner user interface 12, for example suitably embodied by an illustrative computer 14 or other electronic data processing device with user-interfacing hardware (e.g., an LCD display or other-type display, a keyboard, mouse, and/or other user input device(s), or so forth).
  • the MR scanner 10 maybe any commercial MR scanner, such as an AchievaTM, IngeniaTM, InteraTM, or PanoramaTM MR scanner available from Koninklijke Philips Electronics N.V., Eindhoven, The Netherlands, or a commercial MR scanner from another vendor.
  • the MR scanner 10 can be a custom-built or modified MR scanner.
  • a patient or other human subject is loaded into the MR scanner 10.
  • Various preparatory operations may be performed, such as immobilizing the patient, loading local MR coils, or so forth. While imaging of a human subject is described, it is also contemplated to image a veterinary subject (e.g., dog or cat), or a mummy, cadaver, or other deceased human or animal subject, or an inanimate object.
  • a veterinary subject e.g., dog or cat
  • a mummy, cadaver or other deceased human or animal subject, or an inanimate object.
  • the radiologist or other user selects an imaging protocol from a protocols library 16.
  • the protocol is selected based on considerations such as the type of image contrast that is desired (e.g., T1 contrast, T2 contrast, T2* contrast, diffusion weighted contrast, et cetera), the type of tissue to be imaged (e.g., brain imaging, cardiac imaging, et cetera), the size and dimensions of the imaging volume of interest, and so forth.
  • the user also selects parameter values for the parameters of the selected protocol.
  • the protocol parameters may, for example, include one or more of the following: time-to-echo (TE), repetition time (TR), excitation flip angle (FA), parameters defining a preparatory radio frequency (RF) or magnetic field gradient pulse or set of such preparatory pulses, or so forth.
  • TE time-to-echo
  • TR repetition time
  • FA excitation flip angle
  • RF preparatory radio frequency
  • the protocol parameters may also include image reconstruction parameters such as reconstruction algorithm, resolution, filtering parameters, or so forth.
  • the imaging protocol with a particular set of parameter values is referred to herein as an imaging sequence.
  • the protocols library 16 may store default parameter values for the selected protocol, and the selected protocol with the default parameter values is referred to herein as the default imaging sequence.
  • the user may choose to perform the imaging using the default parameter values, or may choose to adjust the value of one or more parameters.
  • the selected protocol is provided with default parameters in the library 16, it is also contemplated for the protocol to have no default parameter values, in which case the user will select all parameter values.
  • the imaging sequence is thus obtained, comprising the protocol with the parameter values chosen by the user (where "chosen” encompasses the possibility that the user chooses to retain the default parameter value).
  • the user instructs the MR scanner 10 via the MR user interface 12 to perform the imaging sequence so as to cause the MR scanner 10 to execute the imaging sequence and acquire MR imaging data.
  • the imaging protocol is considered to include the image reconstruction process, in which case execution of the imaging sequence also includes reconstructing the MR imaging data in accordance with the selected reconstruction parameter values in order to generate one or more reconstructed MR images.
  • the imaging protocol is not deemed to include the reconstruction process, in which case MR imaging data is acquired in accord with the imaging sequence and the MR imaging data is reconstructed to generate one or more reconstructed MR images - but in these embodiments the reconstruction process is not in accord with parameters of the imaging protocol).
  • the one or more reconstructed images can be variously used.
  • the images may be reviewed on the display of the computer 14, printed using a suitable graphical marking engine, and/or stored in a Picture Archiving and Communications Service (PACS) 20, for example stored in accord with the Digital Imaging and COmmunication in Medicine (DICOM) standard.
  • PACS Picture Archiving and Communications Service
  • the PACS 20 is suitably embodied by a server 22 or other electronic data processing device.
  • the PACS may be embodied by the same computer that embodies the MR scanner user interface.
  • the PACS 20 may receive and archive images acquired from other (i.e., "external") image sources 24, e.g. other MR laboratories or other hospitals.
  • the system further includes a contrast strength assessment module 30 which is configured to analytically compute a contrast signal score for the MR imaging sequence.
  • the contrast strength assessment module 30 suitably computes the contrast signal score for the MR imaging sequence respective to a contrast type to be scored (e.g., T1 weighted contrast, T2 weighted contrast, T2* weighted contrast, diffusion weighted contrast, et cetera) using a scoring equation.
  • the computation is based on MR physics, not on empirical measurements of the subject.
  • the image contrast is due to a change in the measured MR signal due to a (usually relatively small) change in a characteristic that varies within the region being imaged.
  • the contrast is due to relatively small differences in the T1 relaxation time of different tissues (e.g., water versus fat versus bone, et cetera).
  • T2 weighted imaging shows contrast for differences in the T2 relaxation time of different tissue types.
  • the contrast is due to relatively small differences in MR signal due to local variations in molecular diffusion.
  • the scoring equation suitably includes a partial derivative ⁇ S p ⁇ p where p denotes an expected value for the characteristic producing the contrast to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence for a substance having the expected value p for the characteristic producing the contrast to be scored.
  • S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of characteristic p whose variation gives rise to the contrast type to be scored.
  • characteristic p whose variation gives rise to the T1 contrast is the T1 relaxation time of the various imaged tissues.
  • T2 weighed contrast the characteristic p whose variation gives rise to the T2 contrast is the T2 relaxation time of the various imaged tissues.
  • the characteristic p whose variation gives rise to the contrast type to be scored does not have to be a tissue characteristic.
  • the characteristic p may be blood velocity (for time-of-flight MRA), or exogenous contrast agent concentration (when using an administered exogenous vascular contrast agent such as a gadolinium-based magnetic contrast agent).
  • the signal S(p) is expected to vary relatively smoothly and relatively slowly with changes in the value of the characteristic p, the precise choice of the "expected value" of the characteristic p is usually not critical.
  • the expected value p can be the T1 relaxation time for grey water or for white matter or for some average or "composite" tissue (e.g. an average of the relaxation times for grey and white matter).
  • the scoring equation can be approximate, for example using a difference approximation for the partial derivative ⁇ S p ⁇ p .
  • a difference approximation is chosen in which a difference ⁇ p corresponds to an expected actual difference in the subject.
  • a suitable difference approximation is ⁇ S p ⁇ p ⁇ S p grey ⁇ S p white p grey ⁇ p white .
  • the partial derivative ⁇ S p ⁇ p it is contemplated for the partial derivative ⁇ S p ⁇ p to include an absolute value operation to ensure a positive contrast signal score.
  • this illustrative difference approximation becomes ⁇ S p ⁇ p ⁇ S T 1 , grey ⁇ S T 1 , white T 1 , grey ⁇ T 1 , white where T 1, grey is the T1 relaxation time of grey brain matter and T 1, white is the T1 relaxation time of white brain matter.
  • the contrast strength assessment module 30 includes or has access to a database containing the contrast signal scoring equations 32.
  • the contrast strength assessment module 30 also includes or has access to a tissue properties database 34 which stores values for at least those tissue properties used in the scoring equations 32. These values typically include representative T1, T2, and T2* relaxation times for tissue expected to be considered during the imaging. These values may be dependent on the strength of the main field of the MR system (e.g. IT, 1.5T, 3T, or 7T) or of other parameters, such as the room temperature. If the contrast strength assessment module 30 is configured to score diffusion weighted contrast, then the tissue properties database 34 suitably includes representative molecular diffusion parameters.
  • the stored tissue properties may include other tissue property values needed to compute the MR signal S(p) based on MR physics, e.g. magnetic permeability values of the tissue or so forth. It should also be noted that in the case of inanimate object imaging applications, the tissue properties database may be replaced by an analogous substance properties database.
  • the contrast strength assessment module 30 can be utilized in various aspects of the MR imaging process.
  • the illustrative MR scanner user interface 12 includes a sequence contrast assessment module 40 which uses the contrast strength assessment module 30 to assess the strength of various contrast types for the imaging sequence so as to identify the dominant contrast type provided by the sequence. Since the contrast strength assessment module 30 computes the contrast signal score analytically, it is fast and so the sequence contrast assessment module 40 can be invoked immediately after each adjustment of any protocol parameter value. In this way, the user can be informed immediately if the parameter value adjustment would have the effect of changing the dominant contrast type of the imaging sequence.
  • the protocols library 16 includes a default sequence contrast classifier 42.
  • the protocols stored in the protocols library 16 are designed by experts in magnetic resonance imaging to provide a desired contrast type, and toward this end typically the protocol will include a set of default parameters (thus defining a default imaging sequence) that the expert considers to provide the desired contrast.
  • the sequence contrast classifier 42 invokes the contrast strength assessment module 30 to apply the contrast signal scoring equations 32 so as to determine which contrast type is dominant.
  • the PACS 20 includes a post-acquisition contrast classifier 44 that labels images by contrast type.
  • the PACS 20 employs a DICOM format or other storage format that includes image metadata
  • the images may be (and in the case of the DICOM format usually are) labeled with contrast type, along with metadata identifying the imaging protocol and the protocol parameter values used in the image acquisition.
  • the contrast type label is usually assigned manually, by the radiologist or other user based on personal expertise. Again, the subjectivity of defining the dominant contrast type means that this manual labeling may have some undesirable variance. Such variance can be problematic if medical personnel look to the PACS 20 as a reference images database since differences in contrast type can complicate or invalidate image comparisons.
  • the post-acquisition contrast classifier 44 retrieves the image metadata identifying the protocol and protocol parameters used in the acquisition and invokes the contrast strength assessment module 30 to apply the appropriate contrast signal scoring equation 32 to determine the dominant contrast type, and the post-acquisition contrast classifier 44 then labels the image with that contrast type.
  • the automatically generated contrast type label can be stored as an image metadata element that is separate from the manually applied contrast type label, or the automatically generated contrast type label can replace the manually applied contrast type label in the image metadata.
  • the module 30 receives as input from the MR scanner user interface 12 the imaging sequence (defined by the protocol selected by the user and the current protocol parameter values), the tissue type (optional; in some embodiments the tissue type is an a priori known value), and the contrast type to be scored.
  • the imaging sequence defined by the protocol and protocol parameters may, for example, be an inversion recovery (IR) sequence, a spin echo (SE) sequence, a fast field echo (FFE) sequence, or so forth.
  • the imaging sequence may be configured to acquire two-dimensional data (e.g., a slice), three-dimensional data, or a set of multiple (sequential) two-dimensional (M2D) slices.
  • the imaging sequence may also employ a fast acquisition mode, e.g. echo planar imaging (EPI), turbo spin echo (TSE) imaging, turbo field echo (TFE) imaging, gradient and spin echo (GRASE) imaging, various combinations thereof (e.g., TFEEPI), or so forth.
  • a fast acquisition mode e.g. echo planar imaging (EPI), turbo spin echo (TSE) imaging, turbo field echo (TFE) imaging, gradient and spin echo (GRASE) imaging, various combinations thereof (e.g., TFEEPI), or so forth.
  • EPI echo planar imaging
  • TSE turbo spin echo
  • TFE turbo field echo
  • GRASE gradient and spin echo
  • various combinations thereof e.g., TFEEPI
  • the signal equation describes the MR signal intensity as a function of the protocol parameters (such as echo time TE, repetition time TR, flip angle FA, and so forth) and known contrast parameters reflecting tissue properties (such as T1 relaxation and T2 relaxation rates).
  • the signal scoring equation suitably incorporates the partial derivative ⁇ S p ⁇ p of the MR signal respective to the expected relaxation time p for the contrast type to be score (in the case of T1, T2, or T2* weighted contrast) or other characteristic p producing the contrast to be scored (e.g., in the case of diffusion weighted contrast).
  • an illustrative embodiment of the sequence contrast assessment module 40 utilized by the MR scanner user interface 12 is described.
  • the user selects the protocol having default parameter values (i.e. a default imaging sequence) designed to provide an intended contrast type.
  • the user adjusts one or more of the parameter values to generate a protocol with adjusted parameter values 64.
  • the operations 60, 62 are suitably performed using the MR scanner user interface 12; however, some of the parameter value adjustments may be done other than explicitly. For example, in a multi-slice imaging technique having a minimized TR, adjustment of the number of slices indirectly causes adjustment of TR.
  • the sequence contrast assessment module 40 is invoked.
  • the module 40 computes, for each considered contrast type, the contrast signal score for the imaging sequence defined by the protocol and the adjusted protocol parameter values 64.
  • the intended contrast type of the default sequence chosen in operation 60 is T2 weighted contrast.
  • the operation 70 suitably computes a contrast signal score for each of T1 weighting, T2 weighting and (optionally) T2* weighting.
  • the operation 70 computes the contrast signal scores by invoking the contrast strength assessment module 30 for each considered contrast type.
  • the output of the operation 70 is a set of contrast signal scores for a set of contemplated contrast types.
  • An operation 72 then classifies the dominant contrast type based on the contrast signal scores.
  • an illustrative dominant contrast type classification system for considered contrast types of proton density weighted contrast (PDW), T1 weighted contrast (T1W), and T2 weighted contrast (T2W) employs a series of threshold numbers a 1 ⁇ b 1 ⁇ c 1 and a 2 ⁇ b 2 ⁇ c 2 .
  • the contrast signal scores are suitably represented as score ( T 1) for T1W and score(T2) for T2W where T 1 and T 2 are the expected T1 and T2 relaxation times, respectively.
  • T 1 and T 2 are representative values, e.g. grey matter T1, or white matter T1, or an average of grey matter and white matter T1).
  • the following dominant contrast type classes can be defined for a spin echo (SE) sequence: Dominant contrast type classification rules score ( T 1) ⁇ a 1 and score ( T 2) ⁇ a 2 ⁇ PDW score ( T 1) ⁇ a 1 and a 2 ⁇ score ( T 2) ⁇ b 2 ⁇ Weak T2W score ( T 1) ⁇ a 1 and b 2 ⁇ score ( T 2) ⁇ c 2 ⁇ T2W score ( T 1) ⁇ a 1 and score ( T 2) > c 2 ⁇ Strong T2W a 1 ⁇ score ( T 1) ⁇ b 1 and score ( T 2) ⁇ a 2 ⁇ Weak T1W b 1 ⁇ score ( T 1) ⁇ c 1 and score ( T 2) ⁇ a 2 ⁇ T1W score ( T 1) > c 1 and score ( T 2) ⁇ a 2 ⁇ ⁇ PDW score
  • contrast type classes listed above may be unachievable for the particular imaging protocol and the tissue being imaged.
  • contrast type classes achievable for a spin echo (SE) sequence imaging grey brain matter are shown.
  • the contrast class labels are mapped as function of echo time (TE) and repetition time (TR) in case of grey matter as reference tissue and 1.5T as field strength.
  • TE echo time
  • TR repetition time
  • the blend of strong T1 and strong T2 contrast is not achievable.
  • the proton density weighting is obtained when both T1W and T2W contrast are weak (i.e., score ( T 1) ⁇ a 1 and score(T2) ⁇ a 2 ).
  • score ( T 1) ⁇ a 1 and score(T2) ⁇ a 2
  • PDW occurs for short TE and long TR - under these conditions the magnetic resonance signal has not appreciably decayed due to either T1 relaxation or T2 relaxation, and so differences in T1 or T2 relaxation time amongst different tissues does not provide contrast in the PDW image.
  • the area grayed out in the lower right of FIGURE 4 corresponds to the physically unrealizable condition of TE>TR.
  • a suitable output is generated to inform the user about the contrast type scores.
  • the operation 74 displays a textual representation 80 of the contrast scores for the relevant contrast types on a display device 82 of the computer 14 (see also FIGURE 1 ) implementing the MR scanner user interface 12.
  • the absolute scores for the contrast types can be displayed, or alternative a percent change (or other relative change) of the contrast scores can be displayed respective to the scores for the default imaging sequence (or respective to another suitable scores baseline).
  • Another option is to display a ratio of contrast scores, e.g. T2 contrast score/T1 contrast score.
  • a visual representation such as bars of lengths corresponding to the scores is also contemplated.
  • a warning or some other type of remedial action is performed.
  • the operation 74 displays a textual warning 84 on the display device 82.
  • the textual warning 84 may include coloration (e.g. red background and/or red text) or animation (e.g. flashing) to increase likelihood that the user will notice the warning 84.
  • Another possible remedial action taken alone or in combination with the scores display 80 and the optional warning 84, is to "undo" (or refuse to accept) the protocol parameter adjustment that changed the predicted contrast type from the intended contrast type. It is also contemplated to provide the warning 84 without the scores display 80.
  • a variant of the sequence contrast assessment module 40 is suitably employed in the default sequence contrast classifier 42 of the protocols library 16.
  • the input to the sequence contrast assessment module 40 is the default sequence defined by the protocol and its default parameter values, and the operation 74 is replaced by a protocol tagging operation that tags the protocol with the dominant contrast type class output by the operation 72.
  • a variant of the sequence contrast assessment module 40 is also suitably employed in the post-acquisition contrast classifier 44 of the PACS 20.
  • the input to the sequence contrast assessment module 40 is the protocol and protocol parameter values tagged to the image stored in the PACS 20, and the operation 74 is replaced by an image tagging operation that tags the image with the dominant contrast type class output by the operation 72.
  • the tagging operation may be performed in combination with a warning delivered to the user if the original contrast type label of the protocol or image differs from that generated by the classification operation 72.
  • the contrast strength assessment module 30 of FIGURE 2 may find other applications.
  • the sequence contrast assessment module 40 provides a warning via the user interface 12 if the manually adjusted parameter values take the sequence away from the intended contrast type.
  • more affirmative assistance is provided.
  • the partial derivatives of the scoring equation respective to the various parameters of the set of parameters of the imaging protocol can be evaluated (again using difference approximations) to determine which parameter is most affecting the contrast. For example, let P max denote the parameter having the most effect on contrast type p, as indicated by partial derivative ⁇ score p ⁇ P max being larger than for any other protocol parameter.
  • the direction of adjustment of the value of P max is positive if ⁇ score p ⁇ P max > 0 and is negative if ⁇ score p ⁇ P max ⁇ 0 .
  • the amount of the adjustment of the value of P max can be estimated from the magnitude of the partial derivative ⁇ score p ⁇ P max . With this information, a suggested parameter adjustment can be displayed based on the evaluated partial derivative.
  • the matrix of partial derivatives ⁇ score p ⁇ P for all protocol parameters P can be computed, and this matrix used in an optimization algorithm such as the Levenberg-Marquardt algorithm or a gradient descent method to optimize the values of the set of parameters to maximize the value of score(p) for the contrast type p .
  • an optimization algorithm such as the Levenberg-Marquardt algorithm or a gradient descent method to optimize the values of the set of parameters to maximize the value of score(p) for the contrast type p .
  • one or more constraints can be placed on the optimization, e.g. maximize score(p) subject to the constraint that score ( p ) is larger than the contrast signal score for any other contrast type, and/or subject to the constraint TE ⁇ TR, or so forth.
  • the parameter values are iteratively optimized to maximize the contrast type p to be scored (e.g., to maximize score(p)) where each iteration includes evaluating partial derivatives ⁇ score p ⁇ P of the scoring equation respective to parameters P of the set of parameters of the imaging protocol and adjusting one or more of the parameter values based on the evaluated partial derivatives.
  • the user is then presented with the set of optimized parameter values.
  • FIGURE 6 displays projections of different clinical spin-echo imaging sequences onto the space spanned by score ( T 1) and score(T2) computed as disclosed herein.
  • Each protocol was labeled as T1W (marked with circles in FIGURE 6 ), T2W (marked with " ⁇ " in FIGURE 6 ), or PDW (marked with "+” signs in FIGURE 6 ), according to the protocol name given by the institution.
  • this labeling may not be correct as the operator may have changed the default protocol parameters without modifying the protocol name. Nevertheless, it can be seen that these three different contrast classes are separated by the T1 and T2 score values computed herein. It can also be seen that some overlap is present, suggesting protocol settings that yield mixed contrast and may not be optimal with respect to the desired contrast.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Signal Processing (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Artificial Intelligence (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Evolutionary Computation (AREA)
  • Fuzzy Systems (AREA)
  • Mathematical Physics (AREA)
  • Power Engineering (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Description

  • The following relates to the magnetic resonance arts, magnetic resonance imaging arts, medical imaging arts, imaging session planning arts, image archiving arts, imaging protocol design arts, and so forth.
  • In magnetic resonance (MR) imaging, a radiologist or other operator selects an imaging protocol which defines the structure of the sequence, e.g. the number and arrangement of radio frequency (RF) and magnetic field gradient pulses, readout operations, and so forth. The imaging protocol is usually designed to provide a particular type of contrast, e.g. T1 contrast, T2 contrast, T2* contrast, diffusion weighted contrast, or so forth. In the case of T1, T2, or T2* contrast, the imaging provides contrast for differences in the T1, T2, or T2* (resp.) relaxation time of the tissue or other substance being imaged. Protocol parameters such as the time-to-echo (TE), sequence repetition time (TR), excitation flip angle (FA), and so forth affect the strength of T1, T2, or T2* contrast. In other types of contrast, the protocol includes preparatory or magnetic resonance-manipulative RF pulses and/or magnetic field gradients that are applied to generate the desired contrast. For example, in diffusion weighted imaging the protocol is designed to provide contrast based on local molecular diffusion characteristics.
  • A given protocol has a set of parameters (e.g., TE, TR, FA, parameters defining a preparatory pulse, or so forth). The parameters may have different representations in different protocols. For example, in a multi-slice imaging protocol which acquires a set of slices in response to successive RF excitations, the number of slices may be specified, and the TR value then calculated to be as small as possible (e.g., to facilitate rapid imaging). In this case, adjusting the number of slices impacts the TR value. In such a case, the radiologist may increase or decrease the number of slices in order to adjust image resolution transverse to the slices, or to increase the total imaging volume. In doing so, the radiologist may fail to appreciate that the value of the TR parameter is simultaneously being adjusted.
  • In clinical practice, the radiologist typically has available a library of protocols tailored for various contrast types and for various tissue types. Each protocol usually includes a set of default parameter values, e.g. a default TE, TR, FA, et cetera. The radiologist is not limited to these default parameter values, however, but instead has the option to adjust some or all of the parameter values to optimize the protocol for a particular patient, for a particular imaging situation, or to accommodate personal preferences of the radiologist or of the physician ordering the MR study.
  • Adjusting the protocol parameters requires expert training, and the MR operator is typically a trained radiologist or otherwise qualified person. The radiologist may reference recommendations from MR literature, a published user guide for the MR scanner, Internet-based radiology user forums, or so forth. In practice, however, the radiologist has a scheduled time window in which to perform an imaging session, and usually relies upon personal expertise in making protocol parameter adjustments. It can happen that subtle changes in the parameters have an undesired influence on the resulting image contrast. For example, as already noted, adjusting the slice number in a multi-slice imaging protocol can have a latent impact on the TR value, which in turn can impact contrast.
  • Similar problems can arise if the default protocol is mislabeled in the protocols library. This can occur due to error, or because different medical professionals may have different opinions as to what constitutes a given contrast type. In practice, a given MR image may exhibit a blend of different contrast types, e.g. predominantly T2 contrast but with some T1 contrast as well, and different persons may have different views as to whether a given image exhibits "adequate" T2 contrast.
  • Images with the wrong contrast, or with severely degraded contrast or with a blend of contrasts, can be of little clinical value. The MR images may be misinterpreted, or the entire MR study may need to be redone, which is inconvenient for the patient, costly, and can lead to delay in medical treatment.
  • These problems can extend into post-acquisition image processing or analysis. For example, a Picture Archiving and Communications Service (PACS) is typically employed to archive medical images, for example stored in accord with the Digital Imaging and COmmunication in Medicine (DICOM) standard. A patient's MR images may be compared with images stored in a PACS in order to identify similar cases. While such comparisons can be medically useful, the validity of the comparison can be compromised if the image contrast is different in the patient and archive images. The likelihood of such a difference is increased if the PACS archives images from multiple medical facilities or different imaging laboratories that use different contrast standards. Haacke et al., Magnetic Resonance Imaging. Physical principles and sequence design (1999), teach a system and method comprising using a magnetic resonance imaging sequence, the imaging sequence being defined by an imaging protocol and parameter values for a set of parameters of the imaging protocol; computing a set of contrast signal scores for a set of contrast types, the set of contrast types including at least T1 weighted contrast and T2 weighted contrast, a respective contrast signal score, each contrast signal score being computed using a scoring equation.
  • U.S. Patent 6, 687,527 B1 discloses a system, wherein an image contrast weighting, especially a T1, a T2 and a proton density weighting are determined and displayed, once the user has selected imaging parameters.
  • The following contemplates improved apparatuses and methods that overcome the aforementioned limitations and others.
  • According to one aspect, the invention concerns a non-transitory storage medium storing instructions executable by an electronic data processing device to perform a method including:
    • identifying a magnetic resonance imaging sequence, the imaging sequence being defined by an imaging protocol and parameter values for a set of parameters of the imaging protocol; computing a set of contrast signal scores for a set of contrast types, the set of contrast types including at least T1 weighted contrast and T2 weighted contrast, a respective contrast signal score assessing a strength of the respective contrast type for the magnetic resonance imaging sequence, each contrast signal score being computed using a scoring equation, wherein the scoring equation is score p = S p / p p / S p ,
      Figure imgb0001
      where score(p) is the contrast signal score for the contrast type to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of a characteristic p whose variation gives rise to the contrast type to be scored for a tissue type, wherein the characteristic p is any of the following: a T1 relaxation time, a T2 relaxation time, a T2* relaxation time, a blood velocity, and an exogenous contrast agent concentration; and
    • determining a dominant contrast type among the set of contrast types for the magnetic resonance imaging sequence based on the computed contrast signal score using a series of threshold numbers. According to another aspect, an apparatus comprises a non-transitory storage medium as set forth in the immediately preceding paragraph and an electronic data processing device configured to read and execute the instructions stored on the non-transitory storage medium.
  • According to another aspect, the invention concerns a method comprising: identifying a magnetic resonance imaging sequence, the imaging sequence being defined by an imaging protocol and parameter values for a set of parameters of the imaging protocol; computing a set of contrast signal scores for a set of contrast types, the set of contrast types including at least T1 weighted contrast and T2 weighted contrast, a respective contrast signal score assessing a strength of the respective contrast type for the magnetic resonance imaging sequence, each contrast signal score being computed using a scoring equation, wherein the scoring equation is: score p = S p / p p / S p ,
    Figure imgb0002
    where score(p) is the contrast signal score for the contrast type to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of a characteristicp whose variation gives rise to the contrast type to be scored, for a tissue type, wherein the characteristic p is any of the following: a T1 relaxation time, a T2 relaxation time, a T2* relaxation time, a blood velocity, and an exogenous contrast agent concentration; and determining a dominant contrast type among the set of contrast types for the magnetic resonance imaging sequence based on the computed contrast signal score using a series of threshold numbers.
  • One advantage resides in providing real-time feedback on the impact of protocol parameter adjustments on the expected image contrast.
  • Another advantage resides in providing a principled approach for labeling MR imaging protocols and archived MR images as pertaining to image contrast type.
  • Numerous additional advantages and benefits will become apparent to those of ordinary skill in the art upon reading the following detailed description.
  • The invention may take form in various components and arrangements of components, and in various process operations and arrangements of process operations. The drawings are only for the purpose of illustrating preferred embodiments and are not to be construed as limiting the invention.
    • FIGURE 1 diagrammatically shows a system for acquiring and archiving magnetic resonance (MR) images.
    • FIGURE 2 diagrammatically shows the contrast strength assessment module of the system of FIGURE 1.
    • FIGURE 3 diagrammatically shows the sequence contrast assessment module of the MRT scanner/user interface of the system of FIGURE 1.
    • FIGURE 4 diagrammatically shows an illustrative contrast type map for a TE-TR parameter space in the case of a spin echo (SE) sequence imaging grey matter in the brain.
    • FIGURE 5 diagrammatically shows a contemplated warning message displayed when the sequence contrast assessment module detects that an adjusted imaging sequence is likely to produce an image with the wrong contrast type.
    • FIGURE 6 plots the contrast type assessed using the approach disclosed herein for existing protocols, with each protocol marker being marked by a marker indicating the labeled contrast type of the protocol.
  • With reference to FIGURE 1, amagnetic resonance (MR) scanner 10 is operated by a radiologist or other user via an MR scanner user interface 12, for example suitably embodied by an illustrative computer 14 or other electronic data processing device with user-interfacing hardware (e.g., an LCD display or other-type display, a keyboard, mouse, and/or other user input device(s), or so forth). The MR scanner 10 maybe any commercial MR scanner, such as an Achieva™, Ingenia™, Intera™, or Panorama™ MR scanner available from Koninklijke Philips Electronics N.V., Eindhoven, The Netherlands, or a commercial MR scanner from another vendor. Alternatively, the MR scanner 10 can be a custom-built or modified MR scanner.
  • To perform an image acquisition, a patient or other human subject is loaded into the MR scanner 10. Various preparatory operations may be performed, such as immobilizing the patient, loading local MR coils, or so forth. While imaging of a human subject is described, it is also contemplated to image a veterinary subject (e.g., dog or cat), or a mummy, cadaver, or other deceased human or animal subject, or an inanimate object.
  • The radiologist or other user selects an imaging protocol from a protocols library 16. The protocol is selected based on considerations such as the type of image contrast that is desired (e.g., T1 contrast, T2 contrast, T2* contrast, diffusion weighted contrast, et cetera), the type of tissue to be imaged (e.g., brain imaging, cardiac imaging, et cetera), the size and dimensions of the imaging volume of interest, and so forth. The user also selects parameter values for the parameters of the selected protocol. The protocol parameters may, for example, include one or more of the following: time-to-echo (TE), repetition time (TR), excitation flip angle (FA), parameters defining a preparatory radio frequency (RF) or magnetic field gradient pulse or set of such preparatory pulses, or so forth. In some embodiments the protocol parameters may also include image reconstruction parameters such as reconstruction algorithm, resolution, filtering parameters, or so forth.
  • As used herein, the imaging protocol with a particular set of parameter values is referred to herein as an imaging sequence. The protocols library 16 may store default parameter values for the selected protocol, and the selected protocol with the default parameter values is referred to herein as the default imaging sequence. The user may choose to perform the imaging using the default parameter values, or may choose to adjust the value of one or more parameters. Moreover, while typically the selected protocol is provided with default parameters in the library 16, it is also contemplated for the protocol to have no default parameter values, in which case the user will select all parameter values.
  • The imaging sequence is thus obtained, comprising the protocol with the parameter values chosen by the user (where "chosen" encompasses the possibility that the user chooses to retain the default parameter value). The user instructs the MR scanner 10 via the MR user interface 12 to perform the imaging sequence so as to cause the MR scanner 10 to execute the imaging sequence and acquire MR imaging data. In some embodiments the imaging protocol is considered to include the image reconstruction process, in which case execution of the imaging sequence also includes reconstructing the MR imaging data in accordance with the selected reconstruction parameter values in order to generate one or more reconstructed MR images. (In other contemplated embodiments, the imaging protocol is not deemed to include the reconstruction process, in which case MR imaging data is acquired in accord with the imaging sequence and the MR imaging data is reconstructed to generate one or more reconstructed MR images - but in these embodiments the reconstruction process is not in accord with parameters of the imaging protocol).
  • The one or more reconstructed images can be variously used. For example, the images may be reviewed on the display of the computer 14, printed using a suitable graphical marking engine, and/or stored in a Picture Archiving and Communications Service (PACS) 20, for example stored in accord with the Digital Imaging and COmmunication in Medicine (DICOM) standard. The PACS 20 is suitably embodied by a server 22 or other electronic data processing device. In some embodiments (not illustrated), the PACS may be embodied by the same computer that embodies the MR scanner user interface. Moreover, the PACS 20 may receive and archive images acquired from other (i.e., "external") image sources 24, e.g. other MR laboratories or other hospitals.
  • With continuing reference to FIGURE 1, the system further includes a contrast strength assessment module 30 which is configured to analytically compute a contrast signal score for the MR imaging sequence. The contrast strength assessment module 30 suitably computes the contrast signal score for the MR imaging sequence respective to a contrast type to be scored (e.g., T1 weighted contrast, T2 weighted contrast, T2* weighted contrast, diffusion weighted contrast, et cetera) using a scoring equation. The computation is based on MR physics, not on empirical measurements of the subject. In its general form, the image contrast is due to a change in the measured MR signal due to a (usually relatively small) change in a characteristic that varies within the region being imaged. In the case of T1 weighted imaging, the contrast is due to relatively small differences in the T1 relaxation time of different tissues (e.g., water versus fat versus bone, et cetera). Similarly, T2 weighted imaging shows contrast for differences in the T2 relaxation time of different tissue types. In the case of diffusion weighted imaging, the contrast is due to relatively small differences in MR signal due to local variations in molecular diffusion. In view of this, the scoring equation suitably includes a partial derivative S p p
    Figure imgb0003
    where p denotes an expected value for the characteristic producing the contrast to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence for a substance having the expected value p for the characteristic producing the contrast to be scored. Said another way, S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of characteristic p whose variation gives rise to the contrast type to be scored. In the case of scoring T1 weighted contrast, for example, the characteristic p whose variation gives rise to the T1 contrast is the T1 relaxation time of the various imaged tissues. In the case of scoring T2 weighed contrast, the characteristic p whose variation gives rise to the T2 contrast is the T2 relaxation time of the various imaged tissues. The characteristic p whose variation gives rise to the contrast type to be scored does not have to be a tissue characteristic. For example, in the case of magnetic resonance angiography (MRA) the characteristic p may be blood velocity (for time-of-flight MRA), or exogenous contrast agent concentration (when using an administered exogenous vascular contrast agent such as a gadolinium-based magnetic contrast agent). Since the signal S(p) is expected to vary relatively smoothly and relatively slowly with changes in the value of the characteristic p, the precise choice of the "expected value" of the characteristic p is usually not critical. For example, in the case of computing a contrast signal score for T1 weighted contrast for brain protocols, the expected value p can be the T1 relaxation time for grey water or for white matter or for some average or "composite" tissue (e.g. an average of the relaxation times for grey and white matter).
  • The scoring equation can be approximate, for example using a difference approximation for the partial derivative S p p .
    Figure imgb0004
    In some contemplated embodiments a difference approximation is chosen in which a difference Δp corresponds to an expected actual difference in the subject. For example, in the case of brain imaging where the image is intended to distinguish between grey brain matter and white brain matter, a suitable difference approximation is S p p S p grey S p white p grey p white .
    Figure imgb0005
    As will be observed in this illustrative approximation, it is contemplated for the partial derivative S p p
    Figure imgb0006
    to include an absolute value operation to ensure a positive contrast signal score. In the case of T1 weighting for brain imaging, this illustrative difference approximation becomes S p p S T 1 , grey S T 1 , white T 1 , grey T 1 , white
    Figure imgb0007
    where T 1,grey is the T1 relaxation time of grey brain matter and T 1,white is the T1 relaxation time of white brain matter. As another illustrative example, the scoring equation can be: score p = S p p p S p S p + 0.5 Δ p S p 0.5 Δ p S p Δ p p
    Figure imgb0008
    where Δp = δ · p for some small δ and again an absolute value operation can optionally be added to ensure positive contrast signal scores.
  • With continuing reference to FIGURE 1, the contrast strength assessment module 30 includes or has access to a database containing the contrast signal scoring equations 32. The contrast strength assessment module 30 also includes or has access to a tissue properties database 34 which stores values for at least those tissue properties used in the scoring equations 32. These values typically include representative T1, T2, and T2* relaxation times for tissue expected to be considered during the imaging. These values may be dependent on the strength of the main field of the MR system (e.g. IT, 1.5T, 3T, or 7T) or of other parameters, such as the room temperature. If the contrast strength assessment module 30 is configured to score diffusion weighted contrast, then the tissue properties database 34 suitably includes representative molecular diffusion parameters. The stored tissue properties may include other tissue property values needed to compute the MR signal S(p) based on MR physics, e.g. magnetic permeability values of the tissue or so forth. It should also be noted that in the case of inanimate object imaging applications, the tissue properties database may be replaced by an analogous substance properties database.
  • With continuing reference to FIGURE 1, the contrast strength assessment module 30 can be utilized in various aspects of the MR imaging process. For example, the illustrative MR scanner user interface 12 includes a sequence contrast assessment module 40 which uses the contrast strength assessment module 30 to assess the strength of various contrast types for the imaging sequence so as to identify the dominant contrast type provided by the sequence. Since the contrast strength assessment module 30 computes the contrast signal score analytically, it is fast and so the sequence contrast assessment module 40 can be invoked immediately after each adjustment of any protocol parameter value. In this way, the user can be informed immediately if the parameter value adjustment would have the effect of changing the dominant contrast type of the imaging sequence.
  • As another illustrative application, the protocols library 16 includes a default sequence contrast classifier 42. Typically, the protocols stored in the protocols library 16 are designed by experts in magnetic resonance imaging to provide a desired contrast type, and toward this end typically the protocol will include a set of default parameters (thus defining a default imaging sequence) that the expert considers to provide the desired contrast. However, there is some subjectivity in assessment of the contrast type of a sequence since the overall contrast is typically a blend of various contrast types. The sequence contrast classifier 42 invokes the contrast strength assessment module 30 to apply the contrast signal scoring equations 32 so as to determine which contrast type is dominant. By applying the same set of equations 32 to all default sequences of the protocol library 16 a more uniform standard is provided for labeling the contrast type of the default sequences.
  • As another illustrative application, the PACS 20 includes a post-acquisition contrast classifier 44 that labels images by contrast type. If the PACS 20 employs a DICOM format or other storage format that includes image metadata, then the images may be (and in the case of the DICOM format usually are) labeled with contrast type, along with metadata identifying the imaging protocol and the protocol parameter values used in the image acquisition. However, the contrast type label is usually assigned manually, by the radiologist or other user based on personal expertise. Again, the subjectivity of defining the dominant contrast type means that this manual labeling may have some undesirable variance. Such variance can be problematic if medical personnel look to the PACS 20 as a reference images database since differences in contrast type can complicate or invalidate image comparisons. Accordingly, the post-acquisition contrast classifier 44 retrieves the image metadata identifying the protocol and protocol parameters used in the acquisition and invokes the contrast strength assessment module 30 to apply the appropriate contrast signal scoring equation 32 to determine the dominant contrast type, and the post-acquisition contrast classifier 44 then labels the image with that contrast type. The automatically generated contrast type label can be stored as an image metadata element that is separate from the manually applied contrast type label, or the automatically generated contrast type label can replace the manually applied contrast type label in the image metadata.
  • With reference to FIGURE 2, an illustrative example of the contrast strength assessment module 30 is shown. The module 30 receives as input from the MR scanner user interface 12 the imaging sequence (defined by the protocol selected by the user and the current protocol parameter values), the tissue type (optional; in some embodiments the tissue type is an a priori known value), and the contrast type to be scored. The imaging sequence defined by the protocol and protocol parameters may, for example, be an inversion recovery (IR) sequence, a spin echo (SE) sequence, a fast field echo (FFE) sequence, or so forth. The imaging sequence may be configured to acquire two-dimensional data (e.g., a slice), three-dimensional data, or a set of multiple (sequential) two-dimensional (M2D) slices. The imaging sequence may also employ a fast acquisition mode, e.g. echo planar imaging (EPI), turbo spin echo (TSE) imaging, turbo field echo (TFE) imaging, gradient and spin echo (GRASE) imaging, various combinations thereof (e.g., TFEEPI), or so forth. In an operation 50, the module 30 then selects the signal scoring equation appropriate for the protocol and for the contrast type to be scored. In an operation 52 the selected signal scoring equation is applied for the tissue type and parameter values to generate a contrast signal score 54 for the contrast to be scored.
  • The signal equation describes the MR signal intensity as a function of the protocol parameters (such as echo time TE, repetition time TR, flip angle FA, and so forth) and known contrast parameters reflecting tissue properties (such as T1 relaxation and T2 relaxation rates). As already noted, the signal scoring equation suitably incorporates the partial derivative S p p
    Figure imgb0009
    of the MR signal respective to the expected relaxation time p for the contrast type to be score (in the case of T1, T2, or T2* weighted contrast) or other characteristic p producing the contrast to be scored (e.g., in the case of diffusion weighted contrast). Some suitable analytical expressions of the signal equation S(p) for various imaging sequences can be found in the literature, for example: van der Meulen et al, MRI; 6:355-368 (1988); Haacke et al. Magnetic Resonance Imaging. Physical principles and sequence design (1999); Busse et al, MRM, 44:339-348 (2000); Bernstein et al. Handbook of MRI Pulse Sequences (2004); and Liang and Lauterbur, Principles of Magnetic Resonance Imaging, A Signal Processing Perspective (2000).
  • With reference to FIGURE 3, an illustrative embodiment of the sequence contrast assessment module 40 utilized by the MR scanner user interface 12 is described. In an operation 60 the user selects the protocol having default parameter values (i.e. a default imaging sequence) designed to provide an intended contrast type. In an operation 62 the user adjusts one or more of the parameter values to generate a protocol with adjusted parameter values 64. The operations 60, 62 are suitably performed using the MR scanner user interface 12; however, some of the parameter value adjustments may be done other than explicitly. For example, in a multi-slice imaging technique having a minimized TR, adjustment of the number of slices indirectly causes adjustment of TR.
  • Each time an adjusted set of parameter values 64 is generated, the sequence contrast assessment module 40 is invoked. In an operation 70, the module 40 computes, for each considered contrast type, the contrast signal score for the imaging sequence defined by the protocol and the adjusted protocol parameter values 64. For example, consider an illustrative example in which the intended contrast type of the default sequence chosen in operation 60 is T2 weighted contrast. The operation 70 suitably computes a contrast signal score for each of T1 weighting, T2 weighting and (optionally) T2* weighting. The operation 70 computes the contrast signal scores by invoking the contrast strength assessment module 30 for each considered contrast type.
  • Thus, the output of the operation 70 is a set of contrast signal scores for a set of contemplated contrast types. An operation 72 then classifies the dominant contrast type based on the contrast signal scores. For example, an illustrative dominant contrast type classification system for considered contrast types of proton density weighted contrast (PDW), T1 weighted contrast (T1W), and T2 weighted contrast (T2W) employs a series of threshold numbers a 1 < b 1 < c 1 and a 2 < b 2 < c 2. The contrast signal scores are suitably represented as score(T1) for T1W and score(T2) for T2W where T1 and T2 are the expected T1 and T2 relaxation times, respectively. (Again, T1 and T2 are representative values, e.g. grey matter T1, or white matter T1, or an average of grey matter and white matter T1). In this context, the following dominant contrast type classes can be defined for a spin echo (SE) sequence: Dominant contrast type classification rules
    score(T1) < a 1 and score(T2) < a 2 PDW
    score(T1) < a 1 and a 2 < score(T2) < b 2 Weak T2W
    score(T1) < a 1 and b 2 < score(T2) < c 2 T2W
    score(T1) < a 1 and score(T2) > c 2 Strong T2W
    a 1 < score(T1) < b 1 and score(T2) < a 2 Weak T1W
    b 1 < score(T1) < c 1 and score(T2) < a 2 T1W
    score(T1) > c 1 and score(T2) < a 2 Strong T1W
    a 1 < score(T1) < b 1 and a 2 < score(T2) < b 2 Weak T1W/Weak T2W
    b 1 < score(T1) < c 1 and a 2 < score(T2) < b 2 T1 W/Weak T2W
    score(T1) > c 1 and a 2 < score(T2) < b 2 Strong T1W/Weak T2W
    a 1 < score(T1) < b 1 and b 2 < score(T2) < c 2 Weak T1W/T2W
    b 1 < score(T1) < c 1 and b 2 < score(T2) < c 2 T1W/T2W
    score(T1) > c 1 and b 2 < score(T2) < c 2 Strong T1W/T2W
    a 1 < score(T1) < b 1 and score(T2) > c 2 Weak T1W/Strong T2W
    b 1 < score(T1) < c 1 and score(T2) > c 2 T1W/Strong T2W
    score(T1) > c 1 and score(T2) > c 2 Strong T1W/Strong T2W
  • In practice some contrast type classes listed above may be unachievable for the particular imaging protocol and the tissue being imaged.
  • With reference to FIGURE 4, for example, contrast type classes achievable for a spin echo (SE) sequence imaging grey brain matter are shown. In the illustrative example of FIGURE 2, the contrast class labels are mapped as function of echo time (TE) and repetition time (TR) in case of grey matter as reference tissue and 1.5T as field strength. In this example, a 1 = a 2 = 0.33, b 1 = b 2 = 0.67, and c 1 = c 2 = 1.33. In this example the blend of strong T1 and strong T2 contrast is not achievable. In the foregoing examples, the proton density weighting (PDW) is obtained when both T1W and T2W contrast are weak (i.e., score(T1) < a 1 and score(T2) < a 2). As seen in FIGURE 4, PDW occurs for short TE and long TR - under these conditions the magnetic resonance signal has not appreciably decayed due to either T1 relaxation or T2 relaxation, and so differences in T1 or T2 relaxation time amongst different tissues does not provide contrast in the PDW image. The area grayed out in the lower right of FIGURE 4 corresponds to the physically unrealizable condition of TE>TR.
  • With reference back to FIGURE 3 and with further reference to FIGURE 5, in an operation 74 performed by the sequence contrast assessment module 40, a suitable output is generated to inform the user about the contrast type scores. In some embodiments, the operation 74 displays a textual representation 80 of the contrast scores for the relevant contrast types on a display device 82 of the computer 14 (see also FIGURE 1) implementing the MR scanner user interface 12. The absolute scores for the contrast types can be displayed, or alternative a percent change (or other relative change) of the contrast scores can be displayed respective to the scores for the default imaging sequence (or respective to another suitable scores baseline). Another option is to display a ratio of contrast scores, e.g. T2 contrast score/T1 contrast score. In addition to or instead of textual scores, a visual representation such as bars of lengths corresponding to the scores is also contemplated. Optionally, if the dominant contrast type output by the contrast type classification operation 72 is different from the intended contrast type of the default sequence selected in the operation 60, then a warning or some other type of remedial action is performed. As diagrammatically shown in FIGURE 5, in one such optional warning approach the operation 74 displays a textual warning 84 on the display device 82. The textual warning 84 may include coloration (e.g. red background and/or red text) or animation (e.g. flashing) to increase likelihood that the user will notice the warning 84. Another possible remedial action, taken alone or in combination with the scores display 80 and the optional warning 84, is to "undo" (or refuse to accept) the protocol parameter adjustment that changed the predicted contrast type from the intended contrast type. It is also contemplated to provide the warning 84 without the scores display 80.
  • With continuing reference to FIGURE 3 and with reference back to FIGURE 1, a variant of the sequence contrast assessment module 40 is suitably employed in the default sequence contrast classifier 42 of the protocols library 16. In this case the input to the sequence contrast assessment module 40 is the default sequence defined by the protocol and its default parameter values, and the operation 74 is replaced by a protocol tagging operation that tags the protocol with the dominant contrast type class output by the operation 72. A variant of the sequence contrast assessment module 40 is also suitably employed in the post-acquisition contrast classifier 44 of the PACS 20. In this case the input to the sequence contrast assessment module 40 is the protocol and protocol parameter values tagged to the image stored in the PACS 20, and the operation 74 is replaced by an image tagging operation that tags the image with the dominant contrast type class output by the operation 72. In both the protocol tagging and image tagging operations, the tagging operation may be performed in combination with a warning delivered to the user if the original contrast type label of the protocol or image differs from that generated by the classification operation 72.
  • In addition to the foregoing illustrative application examples, the contrast strength assessment module 30 of FIGURE 2 may find other applications. For example, the sequence contrast assessment module 40 provides a warning via the user interface 12 if the manually adjusted parameter values take the sequence away from the intended contrast type. However, in variant embodiments, more affirmative assistance is provided. For example, the partial derivatives of the scoring equation respective to the various parameters of the set of parameters of the imaging protocol can be evaluated (again using difference approximations) to determine which parameter is most affecting the contrast. For example, let Pmax denote the parameter having the most effect on contrast type p, as indicated by partial derivative score p P max
    Figure imgb0010
    being larger than for any other protocol parameter. Then the direction of adjustment of the value of Pmax is positive if score p P max > 0
    Figure imgb0011
    and is negative if score p P max < 0 .
    Figure imgb0012
    The amount of the adjustment of the value of Pmax can be estimated from the magnitude of the partial derivative score p P max .
    Figure imgb0013
    With this information, a suggested parameter adjustment can be displayed based on the evaluated partial derivative.
  • As a further variant, the matrix of partial derivatives score p P
    Figure imgb0014
    for all protocol parameters P can be computed, and this matrix used in an optimization algorithm such as the Levenberg-Marquardt algorithm or a gradient descent method to optimize the values of the set of parameters to maximize the value of score(p) for the contrast type p. Optionally, one or more constraints can be placed on the optimization, e.g. maximize score(p) subject to the constraint that score(p) is larger than the contrast signal score for any other contrast type, and/or subject to the constraint TE<TR, or so forth. Thus, in this variant the parameter values are iteratively optimized to maximize the contrast type p to be scored (e.g., to maximize score(p)) where each iteration includes evaluating partial derivatives score p P
    Figure imgb0015
    of the scoring equation respective to parameters P of the set of parameters of the imaging protocol and adjusting one or more of the parameter values based on the evaluated partial derivatives. The user is then presented with the set of optimized parameter values.
  • While an optimization approach employing partial derivative of score (p) for the contrast type p is described, other approaches can be used to optimize the parameter values or to otherwise provide parameter value recommendations. For example, optimal parameter values satisfying certain conditions on the contrast type can be found by other methods that only use the score values (simplex algorithm, probabilistic methods, et cetera).
  • With reference to FIGURE 6, the contrast type classification described herein was compared with contrast type classification labels assigned to various imaging sequences by human experts. FIGURE 6 displays projections of different clinical spin-echo imaging sequences onto the space spanned by score(T1) and score(T2) computed as disclosed herein. A total of 1090 spin-echo protocols from 25 different MR scanners (13 with a main field of 1.5T and 12 with a main field of 3T), covering 18 different body parts, are displayed in FIGURE 6. Each protocol was labeled as T1W (marked with circles in FIGURE 6), T2W (marked with "×" in FIGURE 6), or PDW (marked with "+" signs in FIGURE 6), according to the protocol name given by the institution. Note that in some cases, this labeling may not be correct as the operator may have changed the default protocol parameters without modifying the protocol name. Nevertheless, it can be seen that these three different contrast classes are separated by the T1 and T2 score values computed herein. It can also be seen that some overlap is present, suggesting protocol settings that yield mixed contrast and may not be optimal with respect to the desired contrast.
  • The invention has been described with reference to the preferred embodiments. Obviously, modifications and alterations will occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims.

Claims (14)

  1. A non-transitory storage medium storing instructions executable by an electronic data processing device (14, 22) to perform a method including:
    identifying a magnetic resonance imaging sequence, the imaging sequence being defined by an imaging protocol and parameter values for a set of parameters of the imaging protocol;
    computing a set of contrast signal scores for a set of contrast types, the set of contrast types including at least T1 weighted contrast and T2 weighted contrast, a respective contrast signal score assessing a strength of the respective contrast type for the magnetic resonance imaging sequence, each contrast signal score being computed using a scoring equation, wherein the scoring equation is: score p = S p p p S p
    Figure imgb0016
    where score(p) is the contrast signal score for the contrast type to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of a characteristic p whose variation gives rise to the contrast type to be scored for a tissue type, wherein the characteristic p is any one of the following: a T1 relaxation time, a T2 relaxation time, a T2* relaxation time, a blood velocity, and an exogenous contrast agent concentration; and
    determining a dominant contrast type among the set of contrast types for the magnetic resonance imaging sequence based on the computed contrast signal score using a series of threshold numbers.
  2. The non-transitory storage medium of claim 1 wherein the computing includes approximating the partial derivative S p p
    Figure imgb0017
    of the scoring equation using a difference approximation.
  3. The non-transitory storage medium of any one of claims 1-2, wherein the identifying comprises monitoring user inputs to a magnetic resonance scanner user interface (12) to detect (1) user selection of the imaging protocol and (2) user editing that changes one or more of the parameter values.
  4. The non-transitory storage medium of claim 3, the method further includes displaying a visual representation (80) of the computed contrast signal scores via the magnetic resonance user interface (12, 82).
  5. The non-transitory storage medium of any one of claims 3-4 wherein the imaging protocol has an intended contrast type and the method further includes displaying a warning (84) via the magnetic resonance user interface (12, 82) responsive to the determined dominant contrast type for the magnetic resonance imaging sequence being different from the intended contrast type.
  6. The non-transitory storage medium of any one of claims 3-5 wherein the method further comprises optimizing the scoring equation respective to at least one parameter of the set of parameters of the imaging protocol and displaying a suggested parameter adjustment based on the optimizing.
  7. The non-transitory storage medium of any one of claims 1-6 wherein the identifying includes detecting storing of the imaging protocol in a protocols library (16) and the method further comprises labeling the stored imaging protocol with the determined dominant contrast type.
  8. The non-transitory storage medium of any one of claims 1-6 wherein the identifying comprises reading the imaging protocol and the parameter values for the set of parameters of the imaging protocol from metadata stored with a stored magnetic resonance image.
  9. The non-transitory storage medium of claim 8 wherein the method further comprises modifying the metadata stored with the magnetic resonance image to include the determined dominant contrast type.
  10. An apparatus comprising:
    the non-transitory storage medium of any one of claims 1-9; and
    an electronic data processing device (14, 22) configured to read and execute the instructions stored on the non-transitory storage medium.
  11. A method comprising:
    identifying a magnetic resonance imaging sequence, the imaging sequence being defined by an imaging protocol and parameter values for a set of parameters of the imaging protocol;
    computing a set of contrast signal scores for a set of contrast types, the set of contrast types including at least T1 weighted contrast and T2 weighted contrast, a respective contrast signal score assessing a strength of the respective contrast type for the magnetic resonance imaging sequence, each contrast signal score being computed using a scoring equation, wherein the scoring equation is: score p = S p p p S p
    Figure imgb0018
    where score(p) is the contrast signal score for the contrast type to be scored and S(p) denotes the signal generated by the magnetic resonance imaging sequence as a function of a characteristic p whose variation gives rise to the contrast type to be scored, for a tissue type, wherein the characteristic p is any one of the following: a T1 relaxation time, a T2 relaxation time, a T2* relaxation time, a blood velocity, and an exogenous contrast agent concentration; and
    determining a dominant contrast type among the set of contrast types for the magnetic resonance imaging sequence based on the computed contrast signal score using a series of threshold numbers.
  12. The method of claim 11 wherein the identifying comprises detecting user editing of the parameter values via a magnetic resonance scanner user interface (12) and the method further comprises:
    comparing the determined contrast type for the magnetic resonance imaging sequence with an intended contrast type; and
    displaying a warning (84) via the magnetic resonance user interface (12, 82) if the determined dominant contrast type for the magnetic resonance imaging sequence is different from the intended contrast type.
  13. The method of any one of claims 11-12 further comprising:
    optimizing the parameter values to maximize the contrast type to be scored wherein the optimizing includes evaluating partial derivatives of the scoring equation respective to parameters of the set of parameters of the imaging protocol.
  14. The method of any one of claims 11-12 wherein the identifying comprises reading the imaging protocol and the parameter values for the set of parameters of the imaging protocol from metadata stored with a magnetic resonance image and the method further comprises:
    modifying the metadata stored with the magnetic resonance image to include the determined dominant contrast type.
EP13766693.9A 2012-07-16 2013-07-10 Prediction, scoring, and classification of magnetic resonance contrast using a contrast signal scoring equation Active EP2872914B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261671822P 2012-07-16 2012-07-16
PCT/IB2013/055678 WO2014013390A2 (en) 2012-07-16 2013-07-10 Prediction, scoring, and classification of magnetic resonance contrast using contrast signal scoring equation

Publications (2)

Publication Number Publication Date
EP2872914A2 EP2872914A2 (en) 2015-05-20
EP2872914B1 true EP2872914B1 (en) 2020-12-23

Family

ID=49237547

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13766693.9A Active EP2872914B1 (en) 2012-07-16 2013-07-10 Prediction, scoring, and classification of magnetic resonance contrast using a contrast signal scoring equation

Country Status (7)

Country Link
US (1) US9955897B2 (en)
EP (1) EP2872914B1 (en)
JP (1) JP6305401B2 (en)
CN (1) CN104583796B (en)
BR (1) BR112015000875A2 (en)
RU (1) RU2626025C2 (en)
WO (1) WO2014013390A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014091374A2 (en) * 2012-12-12 2014-06-19 Koninklijke Philips N.V. Motion detection and correction method for magnetic resonance diffusion weighted imaging (dwi)
US20170156630A1 (en) * 2015-12-08 2017-06-08 Board Of Regents Of The University Of Texas System System and method for adaptive and patient-specific magnetic resonance imaging
US10444308B2 (en) * 2016-05-31 2019-10-15 Canon Medical Systems Corporation Magnetic resonance imaging apparatus
EP3379281A1 (en) * 2017-03-20 2018-09-26 Koninklijke Philips N.V. Image segmentation using reference gray scale values
US10950343B2 (en) * 2017-06-29 2021-03-16 Siemens Healthcare Gmbh Highlighting best-matching choices of acquisition and reconstruction parameters
EP3451344A1 (en) 2017-09-01 2019-03-06 Koninklijke Philips N.V. Automated consistency check for medical imaging
CN108490377B (en) * 2018-04-03 2020-08-21 上海东软医疗科技有限公司 Method and device for acquiring magnetic resonance dispersion quantification
CN110806553B (en) * 2018-08-06 2022-08-09 西门子(深圳)磁共振有限公司 Protocol parameter selection method and device and magnetic resonance imaging system
EP3617731A1 (en) * 2018-08-29 2020-03-04 Erasmus University Medical Center Rotterdam Magnetic resonance imaging based on transient response signals
EP3742183A1 (en) * 2019-05-20 2020-11-25 Koninklijke Philips N.V. A control system for a magnetic resonance imaging system
US20230297646A1 (en) * 2022-03-18 2023-09-21 Change Healthcare Holdings, Llc System and methods for classifying magnetic resonance imaging (mri) image characteristics
CN117347416B (en) * 2023-10-12 2024-05-31 无锡鸣石峻致医疗科技有限公司 Non-invasive detection method and device for substance components and storage medium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5754697A (en) 1994-12-02 1998-05-19 Fu; Chi-Yung Selective document image data compression technique
US6219571B1 (en) * 1998-04-06 2001-04-17 Board Of Trustees Of The Leland Stanford Junior University Magnetic resonance imaging using driven equilibrium fourier transform
US6687527B1 (en) * 2001-08-28 2004-02-03 Koninklijke Philips Electronics, N.V. System and method of user guidance in magnetic resonance imaging including operating curve feedback and multi-dimensional parameter optimization
DE10155790B4 (en) * 2001-11-14 2005-04-07 Siemens Ag Magnetic resonance imaging using interactive contrast optimization
JP4413504B2 (en) 2003-02-13 2010-02-10 株式会社東芝 Medical image processing apparatus, medical image processing method, and medical image processing program
JP2007508092A (en) 2003-10-13 2007-04-05 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Magnetic resonance imaging system and method
CN101288101A (en) 2005-07-26 2008-10-15 皇家飞利浦电子股份有限公司 Cardiac region detection from motion analysis of small scale reconstruction
RU2008144711A (en) * 2006-04-13 2010-05-20 Конинклейке Филипс Электроникс Н.В. (Nl) EVALUATION OF COIL SENSITIVITY BASED ON WAVE PROPAGATION
US20090207968A1 (en) 2006-06-22 2009-08-20 Koninklijke Philips Electronics N. V. Dual x-ray tube gating
JP5537014B2 (en) * 2007-12-07 2014-07-02 株式会社東芝 Image display device
US7973530B2 (en) * 2008-04-25 2011-07-05 Jan Bertus Marten Marcel Warntjes MRI display with contrast navigation window
JP5481117B2 (en) * 2008-09-29 2014-04-23 株式会社東芝 Magnetic resonance diagnostic apparatus and control method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US20150216440A1 (en) 2015-08-06
WO2014013390A2 (en) 2014-01-23
JP2015522370A (en) 2015-08-06
RU2626025C2 (en) 2017-07-21
EP2872914A2 (en) 2015-05-20
US9955897B2 (en) 2018-05-01
WO2014013390A3 (en) 2014-03-13
RU2015104982A (en) 2016-09-10
CN104583796A (en) 2015-04-29
JP6305401B2 (en) 2018-04-04
BR112015000875A2 (en) 2017-06-27
CN104583796B (en) 2017-10-10

Similar Documents

Publication Publication Date Title
EP2872914B1 (en) Prediction, scoring, and classification of magnetic resonance contrast using a contrast signal scoring equation
Nyúl et al. On standardizing the MR image intensity scale
Clayden et al. Normative development of white matter tracts: similarities and differences in relation to age, gender, and intelligence
US8655038B2 (en) Method and assembly for correcting a relaxation map for medical imaging applications
CN109924978B (en) Characterizing interfering objects within an examination object by means of a medical image data record
Lane et al. Comparison of sagittal T2-weighted BLADE and fast spin-echo MRI of the female pelvis for motion artifact and lesion detection
Vavasour et al. Multicenter measurements of T1 relaxation and diffusion tensor imaging: intra and intersite reproducibility
Ben-Eliezer et al. A new method for cartilage evaluation in femoroacetabular impingement using quantitative T2 magnetic resonance imaging: preliminary validation against arthroscopic findings
Gardener et al. Investigating white matter perfusion using optimal sampling strategy arterial spin labeling at 7 Tesla
Patel et al. The value of delayed phase enhanced imaging in malignant pleural mesothelioma
Fenty et al. Quantitative cartilage degeneration associated with spontaneous osteoarthritis in a guinea pig model
Altinsoy et al. Forensic age estimation in living individuals by 1.5 T magnetic resonance imaging of the knee: a retrospective MRI study
da Silva Jr et al. Magnetic resonance imaging of the fetal brain at 3 Tesla: preliminary experience from a single series
Woermann et al. A fast FLAIR dual‐echo technique for hippocampal T2 relaxometry: first experiences in patients with temporal lobe epilepsy
Shelmerdine et al. Automated data extraction and report analysis in computer-aided radiology audit: practice implications from post-mortem paediatric imaging
US20190206527A1 (en) Register for examinations with contrast agent
Deininger-Czermak et al. Evaluation of ultrashort echo-time (UTE) and fast-field-echo (FRACTURE) sequences for skull bone visualization and fracture detection–A postmortem study
Mayerhoefer et al. Computer-assisted quantitative analysis of bone marrow edema of the knee: initial experience with a new method
Middleton et al. Correlations of diffusion tensor imaging and clinical measures with spinal cord cross-sectional area measurements in pediatric spinal cord injury patients
US20110288399A1 (en) Placental calcification magnetic resonance imaging
Echeverria‐Chasco et al. Multiparametric renal magnetic resonance imaging: A reproducibility study in renal allografts with stable function
Al-Shaari et al. A systematic review of repeatability and reproducibility studies of diffusion tensor imaging of cervical spinal cord
Ngamsombat et al. Evaluation of ultrafast Wave-CAIPI 3D FLAIR in the visualization and volumetric estimation of cerebral white matter lesions
Loh et al. Influence of saturation effects on biexponential liver intravoxel incoherent motion
Grant et al. A pilot study to assess the feasibility of measurement of adrenal gland volume by magnetic resonance imaging

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150216

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PHILIPS GMBH

Owner name: KONINKLIJKE PHILIPS N.V.

17Q First examination report despatched

Effective date: 20200305

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 40/63 20180101ALI20200630BHEP

Ipc: G01R 33/56 20060101ALI20200630BHEP

Ipc: G01R 33/54 20060101AFI20200630BHEP

INTG Intention to grant announced

Effective date: 20200717

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013074885

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1348256

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210115

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602013074885

Country of ref document: DE

Owner name: PHILIPS GMBH, DE

Free format text: FORMER OWNER: PHILIPS GMBH, 20099 HAMBURG, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R084

Ref document number: 602013074885

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: 746

Effective date: 20210202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210323

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1348256

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201223

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20201223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210323

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210423

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013074885

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210423

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

26N No opposition filed

Effective date: 20210924

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210731

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210423

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210710

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20130710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240730

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240724

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240725

Year of fee payment: 12